Evogene Ltd. ( EVGN) - Stock Earnings
EVGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 19, 2026, midnight | — / — | — | — / — | — |
EVGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.3 million USD | 314000 USD |
| 2026Q1 | -5.9 million USD | 334000 USD |
| 2026Q2 | -1.8 million USD | 347000 USD |
| 2026Q4 Est. | — | — |
EVGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.9 million USD | 3.0 million USD |
| 2024 | -16.5 million USD | 5.6 million USD |
| 2025 | -8.5 million USD | 3.9 million USD |
| 2026 Est. | — | — |
EVGN
Price: $0.37
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 71621
Ebitda: -8.5 millionMarket Capitalization: 3.7 million